ÂÜÀòÂÒÂ×

Lynelle Hoch is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as President of the Cell Therapy Organization at Bristol Myers Squibb since April 2001. Throughout a distinguished career at Bristol Myers Squibb, Lynelle has held multiple senior leadership positions, including Senior Vice President of the Cell Therapy Franchise, General Manager for the United Kingdom and Ireland, and Vice President of both Immuno-Oncology Marketing and Oncology Sales. Prior to joining Bristol Myers Squibb, Lynelle worked at DuPont Pharmaceuticals as a Senior Market Research Analyst and Business Analyst. Lynelle Hoch holds a Bachelor of Science degree in Civil Engineering with a minor in Environmental Science from Penn State University.